You are Currently Viewing the 2020 Medicare Plans.
Click here If you Would Like to See
The 2022 Medicare Advantage Plans in Wilkes County GA.
2020 Wilkes County Georgia
Medicare Advantage Plans
There are 10 Medicare Advantage Plans available in Wilkes County GA from 3 different health insurance providers. 0 of these Medicare Advantage plans offer additional gap coverage. The plan with the lowest out of pocket expense is $6700 and the highest out of pocket is $6700. Wilkes County Georgia residents can also pick from 6 Medicare Special Needs Plans. The highest rated plan available in Wilkes County received a 4 overall star rating from CMS and the lowest rated plan is 3.5 stars
(Click the Plan Name for More Details)
(⇅ Click the Header to Sort)
|Humana Gold Choice H8145-069 (PFFS)
|HumanaChoice H5216-142 (PPO)
|HumanaChoice H5216-154 (PPO)
|HumanaChoice H5216-207 (PPO)
|HumanaChoice R3392-002 (Regional PPO)
|UnitedHealthcare Medicare Advantage Choice (Regional PPO)
Return to 2020 Medicare Advantage Plans in Georgia
Medicare Advantage Health Plans Without Drug Coverage
|Plan Name ⇅||Premium||Type||MOOP||Overall
|HumanaChoice H5216-157 (PPO)
||$0||Local PPO *||$6,700||Enroll|
|HumanaChoice R3392-001 (Regional PPO)
||$0||Regional PPO *||$6,700||Enroll|
|Lasso Healthcare (MSA)
|UnitedHealthcare Medicare Advantage Essential (Regional P
||$0||Regional PPO *||$6,700||Enroll|
2020 Medicare Special Needs Plans in Wilkes county Georgia
|Plan Name ⇅||Monthly
|HumanaChoice SNP-DE H5216-205 (PPO D-SNP)||$25.00||$435.0||No||Dual-Eligible|
|HumanaChoice SNP-DE H5216-206 (PPO D-SNP)||$23.60||$435.0||No||Dual-Eligible|
|PruittHealth Premier (HMO I-SNP)||$25.30||$435.0||No||Institutional||NA|
|UnitedHealthcare Dual Complete Choice (Regional PPO D-SNP||$24.70||$435.0||No||Dual-Eligible|
|UnitedHealthcare Medicare Gold (Regional PPO C-SNP)||$13.00||$210.0||No||Chronic or Disabling Condition|
|UnitedHealthcare Medicare Silver (Regional PPO C-SNP)||$2.80||$435.0||No||Chronic or Disabling Condition|
Plan Type Is the type of organization offering the Medicare Plans.
- HMO - Health Maintenance Organization
- PPO - Preferred Provider Organization
- PDP - Prescription Drug Plan
- SNP - Special Needs Plan
- POS - Point of Service
- PFFS - Private Fee For Service
Monthly Consolidated Premium (Includes Part C + D) Your premium may be lower depending on your eligibility for medical assistance. Call your provider for details.
Part D Total Premium: The Part D Total Premium is the sum of the Basic and Supplemental Premiums. Note: the Part D Total Premium is net of any Part A/B rebates applied to "buy down" the drug premium for Medicare Advantage; for some plans the total premium may be lower than the sum of the basic and supplemental premiums due to negative basic or supplemental premiums.Benefit Type
- (EA) Enhanced Alternative may offer additional gap coverage which is calculated as the percentage of generic formulary products with coverage above standard generic coverage gap cost-sharing benefit and/or the percentage of brand formulary products covered in addition to the coverage gap discount for applicable drugs.
- (DS) Defined Standard Benefit
- (BA) Basic Alternative
- (AE) Actuarially Equivalent Standard
In 2020 once you and your plan provider have spent $4020 on covered drugs. (combined amount plus your deductible) You will be in the coverage gap. (AKA "donut hole") Once you reach the coverage gap you will pay 25% of the plans cost for covered brand-name prescription drugs and 25% on generic drugs unless your plan offers additional coverage.
Maximum Out-of-Pocket (MOOP) limit on enrollee spending that includes costs for all in-network Part A and Part B Services. NOT Part D - prescription drugs. N/A is defined as Not Applicable
Data as of September 3, 2019.
Star Rating as of October 11, 2019.
For More Information on Ratings Please See the CMS Tech Notes.
Plans are subject to change as contracts are finalized.
Includes 2020 approved contracts. Employer sponsored 800 series and plans under sanction are excluded. For 2020, enhanced alternative may offer additional cost sharing reductions in the gap on a sub-set of the formulary drugs, beyond the standard Part-D benefit.